Industry NewsVentana Medical Systems, Inc. and Astellas Pharma Join Forces to Leverage Novel Companion Diagnostic Tests for Targeted Cancer Treatments
Industry NewsVentana Announces Collaboration to Develop Companion Diagnostics for ImmunoGen's Targeted Anticancer Agents
Product NewsVentana Medical Systems, Inc. and MedImmune Collaborate to Develop a Custom PD-L1 Assay for Immunotherapy Clinical Trials
Product NewsVentana Announces HER2 Companion Diagnostic to Identify Breast Cancer Patients for Roche's Latest Targeted Medicines
Product NewsVentana Receives FDA Clearance for Breast Cancer Image Analysis and Digital Read Application
